CoChat
Sign Up
Cited by 726

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

Høiby, N., Bjarnsholt, T., Moser, C., Bassi, G.L., Coenye, T., Donelli, G., Hall-Stoodley, L., Holá, V., Imbert, C., Kirketerp-Møller, K., Lebeaux, D., Oliver, A., Ullmann, A.J., Williams, C.·2015·Clinical Microbiology and Infection
DOI 10.1016/j.cmi.2014.10.024
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmi.2014.10.024

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 208

  1. Hall-Stoodley, 2012, Towards diagnostic guidelines for biofilm-associated infections, FEMS Immunol Med Microbiol, 65, 127, 10.1111/j.1574-695X.2012.00968.x · DOI
  2. Ramage, 2014, Strength in numbers: antifungal strategies against fungal biofilms, Int J Antimicrob Agents, 43, 114, 10.1016/j.ijantimicag.2013.10.023 · DOI
  3. Lebeaux, 2013, From in vitro to in vivo models of bacterial biofilm-related infections, Pathogens, 288, 10.3390/pathogens2020288 · DOI
  4. Bjarnsholt, 2013, Applying insights from biofilm biology to drug development—can a new approach be developed?, Nat Rev Drug Discov, 12, 791, 10.1038/nrd4000 · DOI
  5. Høiby, 2014, A personal history of research on microbial biofilms and biofilm infections, Pathog Dis, 70, 205, 10.1111/2049-632X.12165 · DOI
  6. Høiby, 2010, Antibiotic resistance of bacterial biofilms, Int J Antimicrob Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI
  7. Stoodley, 2002, Biofilms as complex differentiated communities, Annu Rev Microbiol, 56, 187, 10.1146/annurev.micro.56.012302.160705 · DOI
  8. Bjarnsholt, 2009, Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients, Pediatr Pulmonol, 44, 547, 10.1002/ppul.21011 · DOI
  9. Kirketerp-Møller, 2008, Distribution, organization, and ecology of bacteria in chronic wounds, J Clin Microbiol, 46, 2717, 10.1128/JCM.00501-08 · DOI
  10. Bjarnsholt, 2013, The in vivo biofilm, Trends Microbiol, 21, 466, 10.1016/j.tim.2013.06.002 · DOI · Paper page
  11. Gristina, 1985, Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis, J Bone Joint Surg Am, 67, 264, 10.2106/00004623-198567020-00014 · DOI
  12. Adair, 1999, Implications of endotracheal tube biofilm for ventilator-associated pneumonia, Intensive Care Med, 25, 1072, 10.1007/s001340051014 · DOI
  13. Friedland, 2001, Bacterial colonization of endotracheal tubes in intubated neonates, Arch Otolaryngol Head Neck Surg, 127, 525, 10.1001/archotol.127.5.525 · DOI
  14. Gil-Perotin, 2012, Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept, Crit Care, 16, R93, 10.1186/cc11357 · DOI
  15. Inglis, 1995, Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation, Chest, 108, 1049, 10.1378/chest.108.4.1049 · DOI
  16. Mermel, 2009, Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America, Clin Infect Dis, 49, 1, 10.1086/599376 · DOI · Paper page
  17. Conway, 2012, Guidelines to prevent catheter-associated urinary tract infection: 1980 to 2010, Heart Lung, 41, 271, 10.1016/j.hrtlng.2011.08.001 · DOI
  18. Hooton, 2010, Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America, Clin Infect Dis, 50, 625, 10.1086/650482 · DOI · Paper page
  19. Christensen, 2013, Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery, Clin Infect Dis, 56, 1438, 10.1093/cid/cit067 · DOI
  20. Bjarnsholt, 2009, Detection of bacteria by FISH in culture-negative soft tissue filler lesions, Dermatol Surg, 35, 1620, 10.1111/j.1524-4725.2009.01313.x · DOI
  21. Rieger, 2013, Bacterial biofilms and capsular contracture in patients with breast implants, Br J Surg, 100, 768, 10.1002/bjs.9084 · DOI
  22. Wolcott, 2010, Chronic wounds and the medical biofilm paradigm, J Wound Care, 19
  23. Stoodley, 2005, Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections, Clin Orthop Relat Res, 437, 31, 10.1097/01.blo.0000175129.83084.d5 · DOI
  24. Johannsson, 2010, Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey, Diagn Microbiol Infect Dis, 66, 16, 10.1016/j.diagmicrobio.2009.08.016 · DOI
  25. Cataldo, 2010, Prosthetic joint infection: recent developments in diagnosis and management, J Infect, 61, 443
  26. 2005, Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia, Am J Respir Crit Care Med, 171, 388, 10.1164/rccm.200405-644ST · DOI
  27. Stickler, 2008, Bacterial biofilms in patients with indwelling urinary catheters, Nat Clin Pract Urol, 5, 598, 10.1038/ncpuro1231 · DOI
  28. Viola, 2014, Breast tissue expander-related infections: perioperative antimicrobial regimens, Infect Control Hosp Epidemiol, 35, 75, 10.1086/674390 · DOI
  29. Döring, 2000, Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus, Eur Respir J, 16, 749, 10.1034/j.1399-3003.2000.16d30.x · DOI
  30. Döring, 2004, Early intervention and prevention of lung disease in cystic fibrosis: a European consensus, J Cyst Fibros, 3, 67, 10.1016/j.jcf.2004.03.008 · DOI
  31. Kerem, 2005, Standards of care for patients with cystic fibrosis: a European consensus, J Cyst Fibros, 4, 7, 10.1016/j.jcf.2004.12.002 · DOI
  32. Heijerman, 2009, Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus, J Cyst Fibros, 8, 295, 10.1016/j.jcf.2009.04.005 · DOI
  33. Döring, 2012, Treatment of lung infection in patients with cystic fibrosis: current and future strategies, J Cyst Fibros, 11, 461, 10.1016/j.jcf.2012.10.004 · DOI
  34. Siddiq, 2012, New strategies to prevent catheter-associated urinary tract infections, Nat Rev Urol, 9, 305, 10.1038/nrurol.2012.68 · DOI
  35. Bonkat, 2011, Improved detection of microbial ureteral stent colonisation by sonication, World J Urol, 29, 133, 10.1007/s00345-010-0535-5 · DOI
  36. Osmon, 2013, Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America, Clin Infect Dis, 56, e1, 10.1093/cid/cis803 · DOI
  37. Zimmerli, 2004, Prosthetic-joint infections, N Engl J Med, 351, 1645, 10.1056/NEJMra040181 · DOI
  38. James, 2008, Biofilms in chronic wounds, Wound Repair Regen, 16, 37, 10.1111/j.1524-475X.2007.00321.x · DOI · Paper page
  39. Bjarnsholt, 2008, Why chronic wounds will not heal: a novel hypothesis, Wound Repair Regen, 16, 2, 10.1111/j.1524-475X.2007.00283.x · DOI
  40. Inglis, 1989, Tracheal tube biofilm as a source of bacterial colonization of the lung, J Clin Microbiol, 27, 2014, 10.1128/JCM.27.9.2014-2018.1989 · DOI
  41. Sottile, 1986, Nosocomial pulmonary infection: possible etiologic significance of bacterial adhesion to endotracheal tubes, Crit Care Med, 14, 265, 10.1097/00003246-198604000-00001 · DOI
  42. Berra, 2012, A clinical assessment of the Mucus Shaver: a device to keep the endotracheal tube free from secretions, Crit Care Med, 40, 119, 10.1097/CCM.0b013e31822e9fe3 · DOI
  43. Kollef, 2008, Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial, JAMA, 300, 805, 10.1001/jama.300.7.805 · DOI
  44. Biel, 2011, Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy, Lasers Surg Med, 43, 586, 10.1002/lsm.21103 · DOI
  45. Liu, 2013, Effect of mechanical cleaning of endotracheal tubes with sterile urethral catheters to reduce biofilm formation in ventilator patients, Pediatr Crit Care Med, 14, e338, 10.1097/PCC.0b013e31828aa5d6 · DOI
  46. Zhai, 2014, Sonication fluid of prosthetic components for the diagnosis of infection after total joint arthroplasty: a meta-analysis, J Clin Microbiol, 10.1128/JCM.03138-13 · DOI
  47. Goddard, 2012, Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota, Proc Natl Acad Sci USA, 109, 13769, 10.1073/pnas.1107435109 · DOI
  48. Percival, 2012, A review of the scientific evidence for biofilms in wounds, Wound Repair Regen, 20, 647, 10.1111/j.1524-475X.2012.00836.x · DOI
  49. Lipsky, 2012, Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections, Clin Infect Dis, 54, 1679, 10.1093/cid/cis460 · DOI
  50. Trampuz, 2007, Sonication of removed hip and knee prostheses for diagnosis of infection, N Engl J Med, 357, 654, 10.1056/NEJMoa061588 · DOI
  51. Catelas, 2011, Polyethylene and metal wear particles: characteristics and biological effects, Semin Immunopathol, 33, 257, 10.1007/s00281-011-0242-3 · DOI
  52. Zadaka, 2010, Acute crystal-induced arthritis following arthroplasty, J Knee Surg, 23, 17
  53. Parvizi, 2011, Aseptic loosening of total hip arthroplasty: infection always should be ruled out, Clin Orthop Relat Res, 469, 1401, 10.1007/s11999-011-1822-1 · DOI
  54. Parvizi, 2011, Definition of periprosthetic joint infection: is there a consensus?, Clin Orthop Relat Res, 469, 3022, 10.1007/s11999-011-1971-2 · DOI
  55. Parvizi, 2011, New definition for periprosthetic joint infection, J Arthroplasty, 26, 1136, 10.1016/j.arth.2011.09.026 · DOI
  56. Portillo, 2012, Multiplex PCR of sonication fluid accurately differentiates between prosthetic joint infection and aseptic failure, J Infect, 65, 541
  57. Vandercam, 2008, Amplification-based DNA analysis in the diagnosis of prosthetic joint infection, J Mol Diagn, 10, 537, 10.2353/jmoldx.2008.070137 · DOI
  58. Corvec, 2012, Epidemiology and new developments in the diagnosis of prosthetic joint infection, Int J Artif Organs, 35, 923, 10.5301/ijao.5000168 · DOI
  59. Zimmerli, 2012, Pathogenesis and treatment concepts of orthopaedic biofilm infections, FEMS Immunol Med Microbiol, 65, 158, 10.1111/j.1574-695X.2012.00938.x · DOI
  60. Kolobow, 2005, Novel system for complete removal of secretions within the endotracheal tube: the Mucus Shaver, Anesthesiology, 102, 1063, 10.1097/00000542-200505000-00028 · DOI
  61. Mietto, 2013, Removal of endotracheal tube debris obstruction by a clearing secretion device, Respir Care
  62. Berra, 2004, Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube, Anesthesiology, 100, 1446, 10.1097/00000542-200406000-00017 · DOI
  63. Wilson, 2012, Advanced endotracheal tube biofilm stage, not duration of intubation, is related to pneumonia, J Trauma Acute Care Surg, 72, 916, 10.1097/TA.0b013e3182493a10 · DOI
  64. Fernandez-Barat, 2012, Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy, FEMS Immunol Med Microbiol, 65, 309, 10.1111/j.1574-695X.2012.00961.x · DOI
  65. Fernandez-Barat, 2012, Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes, Crit Care Med, 40, 2385, 10.1097/CCM.0b013e31825332fc · DOI
  66. Brun-Buisson, 1987, Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures, Arch Intern Med, 147, 873, 10.1001/archinte.1987.00370050069012 · DOI
  67. Maki, 1977, A semiquantitative culture method for identifying intravenous-catheter-related infection, N Engl J Med, 296, 1305, 10.1056/NEJM197706092962301 · DOI
  68. Douard, 1999, Diagnosis of venous access port-related infections, Clin Infect Dis, 29, 1197, 10.1086/313444 · DOI
  69. Longuet, 2001, Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool, Clin Infect Dis, 32, 1776, 10.1086/320746 · DOI
  70. Lebeaux, 2014, Management of infections related to totally implantable venous-access ports: challenges and perspectives, Lancet Infect Dis, 14, 146, 10.1016/S1473-3099(13)70266-4 · DOI
  71. Whitman, 1995, Comparison of diagnostic specimens and methods to evaluate infected venous access ports, Am J Surg, 170, 665, 10.1016/S0002-9610(99)80038-5 · DOI
  72. Bouza, 2007, A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal, Clin Infect Dis, 44, 820, 10.1086/511865 · DOI
  73. Guembe, 2013, Value of superficial cultures for prediction of catheter-related bloodstream infection in long-term catheters: a prospective study, J Clin Microbiol, 51, 3025, 10.1128/JCM.01351-13 · DOI
  74. Blot, 1999, Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures, Lancet, 354, 1071, 10.1016/S0140-6736(98)11134-0 · DOI
  75. Raad, 2004, Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections, Ann Intern Med, 140, 18, 10.7326/0003-4819-140-1-200401060-00007 · DOI
  76. Ruhnke, 2011, Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy, Mycoses, 54, 279, 10.1111/j.1439-0507.2011.02040.x · DOI
  77. Chatzinikolaou, 2004, Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study, Diagn Microbiol Infect Dis, 50, 167, 10.1016/j.diagmicrobio.2004.07.007 · DOI
  78. Hachem, 2009, Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results, Antimicrob Agents Chemother, 53, 5145, 10.1128/AAC.00718-09 · DOI
  79. Hola, 2010, Microbial diversity in biofilm infections of the urinary tract with the use of sonication techniques, FEMS Immunol Med Microbiol, 59, 525, 10.1111/j.1574-695X.2010.00703.x · DOI
  80. Morgan, 2009, A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters, Urol Res, 37, 89, 10.1007/s00240-009-0176-6 · DOI
  81. Donelli, 2014, Biofilm-based infections in long-term care facilities, Future Microbiol, 9, 175, 10.2217/fmb.13.149 · DOI
  82. Choe, 2012, Analysis of the distribution of bacteria within urinary catheter biofilms using four different molecular techniques, Am J Infect Control, 40, e249, 10.1016/j.ajic.2012.05.010 · DOI
  83. Frank, 2009, Culture-independent microbiological analysis of foley urinary catheter biofilms, PLoS One, 4, e7811, 10.1371/journal.pone.0007811 · DOI
  84. Xu, 2012, Culture-dependent and -independent investigations of microbial diversity on urinary catheters, J Clin Microbiol, 50, 3901, 10.1128/JCM.01237-12 · DOI
  85. Malic, 2009, Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH), Microbiology, 155, 2603, 10.1099/mic.0.028712-0 · DOI · Paper page
  86. Kobayashi, 2009, Improved detection of biofilm-formative bacteria by vortexing and sonication: a pilot study, Clin Orthop Relat Res, 467, 1360, 10.1007/s11999-008-0609-5 · DOI
  87. Bjerkan, 2009, Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro, Acta Orthop, 80, 245, 10.3109/17453670902947457 · DOI
  88. Kobayashi, 2007, Brief ultrasonication improves detection of biofilm-formative bacteria around a metal implant, Clin Orthop Relat Res, 457, 210, 10.1097/BLO.0b013e3180312042 · DOI
  89. Penterman, 2014, Rapid evolution of culture-impaired bacteria during adaptation to biofilm growth, Cell Rep, 6, 293, 10.1016/j.celrep.2013.12.019 · DOI
  90. Pasquaroli, 2013, Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms, J Antimicrob Chemother, 68, 1812, 10.1093/jac/dkt086 · DOI
  91. Zandri, 2012, Detection of viable but non-culturable staphylococci in biofilms from central venous catheters negative on standard microbiological assays, Clin Microbiol Infect, 18, E259, 10.1111/j.1469-0691.2012.03893.x · DOI
  92. Siegman-Igra, 1997, Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis, J Clin Microbiol, 35, 928, 10.1128/JCM.35.4.928-936.1997 · DOI
  93. Slobbe, 2009, Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective study, J Clin Microbiol, 47, 885, 10.1128/JCM.00998-08 · DOI
  94. Lebeaux, 2012, Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature, Medicine (Baltimore), 91, 309, 10.1097/MD.0b013e318275ffe1 · DOI
  95. Bouza, 2014, Predictive value of superficial cultures to anticipate tunneled hemodialysis catheter-related bloodstream infection, Diagn Microbiol Infect Dis, 78, 316, 10.1016/j.diagmicrobio.2013.12.008 · DOI
  96. Raad, 2007, Intravascular catheter-related infections: advances in diagnosis, prevention, and management, Lancet Infect Dis, 7, 645, 10.1016/S1473-3099(07)70235-9 · DOI
  97. Safdar, 2005, Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection, Ann Intern Med, 142, 451, 10.7326/0003-4819-142-6-200503150-00011 · DOI
  98. Bouza, 2013, Can microbiologists help to assess catheter involvement in candidaemic patients before removal?, Clin Microbiol Infect, 19, E129, 10.1111/1469-0691.12096 · DOI
  99. Percival, 2005, Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm, Infect Control Hosp Epidemiol, 26, 515, 10.1086/502577 · DOI
  100. Pressler, 2009, Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods, J Cyst Fibros, 8, 37, 10.1016/j.jcf.2008.08.002 · DOI
  101. Artini, 2011, Staphylococcal IgM enzyme-linked immunosorbent assay for diagnosis of periprosthetic joint infections, J Clin Microbiol, 49, 423, 10.1128/JCM.01836-10 · DOI
  102. Selan, 2002, Diagnosis of vascular graft infections with antibodies against staphylococcal slime antigens, Lancet, 359, 2166, 10.1016/S0140-6736(02)09086-4 · DOI
  103. Aanaes, 2013, Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization, J Cyst Fibros, 12, 81, 10.1016/j.jcf.2012.07.001 · DOI
  104. Rudkjøbing, 2011, True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis, J Clin Microbiol, 49, 4352, 10.1128/JCM.06092-11 · DOI
  105. Schuetz, 2009, Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial, JAMA, 302, 1059, 10.1001/jama.2009.1297 · DOI
  106. Worthington, 2010, Serum procalcitonin, interleukin-6, soluble intercellular adhesin molecule-1 and IgG to short-chain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision, Br J Biomed Sci, 67, 71, 10.1080/09674845.2010.11730294 · DOI
  107. Kizilbash, 2013, Bacteremia and mortality with urinary catheter-associated bacteriuria, Infect Control Hosp Epidemiol, 34, 1153, 10.1086/673456 · DOI
  108. Høiby, 2007, Foreign body infections—biofilms and quorum sensing, Ugeskr Laeger, 169, 4163
  109. Rodriguez-Tudela, 2010, EUCAST breakpoints for antifungals, Drug News Perspect, 23, 93, 10.1358/dnp.2010.23.2.1400855 · DOI
  110. Moskowitz, 2011, Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection, Pediatr Pulmonol, 46, 184, 10.1002/ppul.21350 · DOI
  111. Moskowitz, 2004, Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis, J Clin Microbiol, 42, 1915, 10.1128/JCM.42.5.1915-1922.2004 · DOI
  112. Waters, 2012, Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis, Cochrane Database Syst Rev, 11, CD009528
  113. Chauhan, 2012, A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections, PLoS One, 7, e37281, 10.1371/journal.pone.0037281 · DOI
  114. Warwick, 2004, Use of quantitative 16S ribosomal DNA detection for diagnosis of central vascular catheter-associated bacterial infection, J Clin Microbiol, 42, 1402, 10.1128/JCM.42.4.1402-1408.2004 · DOI
  115. Larsen, 2008, Use of cultivation-dependent and -independent techniques to assess contamination of central venous catheters: a pilot study, BMC Clin Pathol, 8, 10, 10.1186/1472-6890-8-10 · DOI
  116. Song, 2013, Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms, Orthop Rev (Pavia), 5, 65, 10.4081/or.2013.e14 · DOI
  117. Petronella, 2012, Antibiotic prophylaxis in catheter-associated urinary infections, New Microbiol, 35, 191
  118. Sayin, 2012, Is short course of antimicrobial therapy for asymptomatic bacteriuria before urologic surgical procedures sufficient?, J Infect Dev Ctries, 6, 143, 10.3855/jidc.1781 · DOI
  119. Karanlik, 2011, The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial, Am J Surg, 202, 10, 10.1016/j.amjsurg.2010.05.005 · DOI
  120. Di C, 2011, Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study, Surg Oncol, 20, 20, 10.1016/j.suronc.2009.09.003 · DOI
  121. van de Wetering, 2007, Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients, Cochrane Database Syst Rev, CD003295
  122. O'Meara, 2000, Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration, Health Technol Assess, 4, 1
  123. Howell-Jones, 2005, A review of the microbiology, antibiotic usage and resistance in chronic skin wounds, J Antimicrob Chemother, 55, 143, 10.1093/jac/dkh513 · DOI
  124. Parvizi, 2008, Efficacy of antibiotic-impregnated cement in total hip replacement, Acta Orthop, 79, 335, 10.1080/17453670710015229 · DOI
  125. Marschall, 2013, Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey, Int J Antimicrob Agents, 41, 272, 10.1016/j.ijantimicag.2012.10.023 · DOI
  126. Pickard, 2012, Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial, Lancet, 380, 1927, 10.1016/S0140-6736(12)61380-4 · DOI
  127. Johnson, 2006, Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients, Ann Intern Med, 144, 116, 10.7326/0003-4819-144-2-200601170-00009 · DOI
  128. Gaonkar, 2003, Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model, Infect Control Hosp Epidemiol, 24, 506, 10.1086/502241 · DOI
  129. Gorman, 1993, Influence of selective decontamination of the digestive tract on microbial biofilm formation on endotracheal tubes from artificially ventilated patients, Eur J Clin Microbiol Infect Dis, 12, 9, 10.1007/BF01997050 · DOI
  130. Adair, 2002, Eradication of endotracheal tube biofilm by nebulised gentamicin, Intensive Care Med, 28, 426, 10.1007/s00134-002-1223-8 · DOI
  131. Berra, 2008, Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial, Intensive Care Med, 34, 1030, 10.1007/s00134-008-1100-1 · DOI
  132. Olson, 2002, Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs, Chest, 121, 863, 10.1378/chest.121.3.863 · DOI
  133. Rello, 2006, Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study, Crit Care Med, 34, 2766, 10.1097/01.CCM.0000242154.49632.B0 · DOI
  134. Afessa, 2010, Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia, Chest, 137, 1015, 10.1378/chest.09-0391 · DOI
  135. Ye, 2011, Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States, Am J Infect Control, 39, 647, 10.1016/j.ajic.2010.11.008 · DOI
  136. Timsit, 2012, Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults, Am J Respir Crit Care Med, 186, 1272, 10.1164/rccm.201206-1038OC · DOI
  137. Timsit, 2009, Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial, JAMA, 301, 1231, 10.1001/jama.2009.376 · DOI
  138. Loveday, 2014, epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England, J Hosp Infect, 86, S1, 10.1016/S0195-6701(13)60012-2 · DOI
  139. Darouiche, 1999, A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group, N Engl J Med, 340, 1, 10.1056/NEJM199901073400101 · DOI
  140. Casey, 2008, Antimicrobial central venous catheters in adults: a systematic review and meta-analysis, Lancet Infect Dis, 8, 763, 10.1016/S1473-3099(08)70280-9 · DOI
  141. Gilbert, 2008, Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review, Curr Opin Infect Dis, 21, 235, 10.1097/QCO.0b013e3282ffd6e0 · DOI
  142. Desrousseaux, 2013, Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation, J Hosp Infect, 85, 87, 10.1016/j.jhin.2013.06.015 · DOI
  143. Campos, 2011, Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis, J Am Soc Nephrol, 22, 1939, 10.1681/ASN.2010121306 · DOI
  144. Ferreira Chacon, 2011, Randomized study of minocycline and edetic acid as a locking solution for central line (port-a-cath) in children with cancer, Chemotherapy, 57, 285, 10.1159/000328976 · DOI
  145. Solomon, 2012, Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis, Semin Dial, 25, 233, 10.1111/j.1525-139X.2011.00951.x · DOI
  146. Betjes, 2004, Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution, Nephrol Dial Transplant, 19, 1546, 10.1093/ndt/gfh014 · DOI
  147. Allon, 2003, Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution, Clin Infect Dis, 36, 1539, 10.1086/375234 · DOI
  148. Simon, 2008, Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients, BMC Infect Dis, 8, 102, 10.1186/1471-2334-8-102 · DOI
  149. Dumichen, 2012, Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies, J Hosp Infect, 80, 304, 10.1016/j.jhin.2012.01.003 · DOI
  150. Bisseling, 2010, Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial, Clin Nutr, 29, 464, 10.1016/j.clnu.2009.12.005 · DOI
  151. Broom, 2012, A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients—the HEALTHY-CATH trial, BMC Nephrol, 13, 146, 10.1186/1471-2369-13-146 · DOI
  152. Sanders, 2008, A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients, J Antimicrob Chemother, 62, 809, 10.1093/jac/dkn284 · DOI
  153. Wales, 2011, Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience, J Pediatr Surg, 46, 951, 10.1016/j.jpedsurg.2011.02.036 · DOI
  154. Slobbe, 2010, Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial, PLoS One, 5, e10840, 10.1371/journal.pone.0010840 · DOI
  155. Redelman, 2012, Alcohol treatment enhances Staphylococcus aureus biofilm development, FEMS Immunol Med Microbiol, 66, 411, 10.1111/1574-695X.12005 · DOI
  156. Oliveira, 2012, Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis, Pediatrics, 129, 318, 10.1542/peds.2011-1602 · DOI
  157. Novikov, 2012, Impact of catheter antimicrobial coating on species-specific risk of catheter colonization: a meta-analysis, Antimicrob Resist Infect Control, 1, 40, 10.1186/2047-2994-1-40 · DOI
  158. Walraven, 2013, Antifungal lock therapy, Antimicrob Agents Chemother, 57, 1, 10.1128/AAC.01351-12 · DOI · Paper page
  159. Lai, 2002, Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients, Am J Infect Control, 30, 221, 10.1067/mic.2002.120128 · DOI
  160. Srinivasan, 2006, A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections, Infect Control Hosp Epidemiol, 27, 38, 10.1086/499998 · DOI
  161. Zhao, 2002, Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window, J Infect Dis, 185, 561, 10.1086/338571 · DOI
  162. Vilchez, 2011, Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement, Clin Microbiol Infect, 17, 439, 10.1111/j.1469-0691.2010.03244.x · DOI
  163. Parvizi, 2013, Proceedings of the International Consensus on Periprosthetic Joint Infection, Bone Joint J, 95-B, 1450, 10.1302/0301-620X.95B11.33135 · DOI
  164. Funalleras, 2011, Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study, Clin Infect Dis, 53, e129, 10.1093/cid/cir551 · DOI
  165. Fernandez-Hidalgo, 2006, Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study, J Antimicrob Chemother, 57, 1172, 10.1093/jac/dkl103 · DOI
  166. Rijnders, 2005, Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial, J Antimicrob Chemother, 55, 90, 10.1093/jac/dkh488 · DOI
  167. Fortun, 2006, Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy, J Antimicrob Chemother, 58, 816, 10.1093/jac/dkl318 · DOI
  168. del Pozo, 2009, Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis, Int J Antimicrob Agents, 34, 482, 10.1016/j.ijantimicag.2009.06.020 · DOI
  169. Fowler, 1998, Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients, Clin Infect Dis, 27, 478, 10.1086/514686 · DOI
  170. Fowler, 2005, Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia, Clin Infect Dis, 40, 695, 10.1086/427806 · DOI
  171. Segarra-Newnham, 2005, Antibiotic lock technique: a review of the literature, Ann Pharmacother, 39, 311, 10.1345/aph.1E316 · DOI
  172. Andes, 2012, Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials, Clin Infect Dis, 54, 1110, 10.1093/cid/cis021 · DOI · Paper page
  173. Rex, 1995, Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group, Clin Infect Dis, 21, 994, 10.1093/clinids/21.4.994 · DOI · Paper page
  174. Cornely, 2012, ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clin Microbiol Infect, 18, 19, 10.1111/1469-0691.12039 · DOI · Paper page
  175. Cateau, 2011, Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone, Int J Antimicrob Agents, 37, 380, 10.1016/j.ijantimicag.2010.12.016 · DOI
  176. Toulet, 2012, Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?, J Antimicrob Chemother, 67, 430, 10.1093/jac/dkr473 · DOI
  177. Bensel, 2011, Lactate in cystic fibrosis sputum, J Cyst Fibros, 10, 37, 10.1016/j.jcf.2010.09.004 · DOI
  178. Hengzhuang, 2011, Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 55, 4469, 10.1128/AAC.00126-11 · DOI
  179. Hengzhuang, 2012, In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection, Antimicrob Agents Chemother, 56, 2683, 10.1128/AAC.06486-11 · DOI
  180. Hengzhuang, 2013, High beta-lactamase levels change the pharmacodynamics of beta-lactam antibiotics in Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 57, 196, 10.1128/AAC.01393-12 · DOI
  181. Lebrun, 2010, The role of surgical debridement in healing of diabetic foot ulcers, Wound Repair Regen, 18, 433, 10.1111/j.1524-475X.2010.00619.x · DOI
  182. Caputo, 2008, A prospective randomised controlled clinical trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers, Int Wound J, 5, 288, 10.1111/j.1742-481X.2007.00490.x · DOI
  183. Sendi, 2012, Antimicrobial treatment concepts for orthopaedic device-related infection, Clin Microbiol Infect, 18, 1176, 10.1111/1469-0691.12003 · DOI
  184. Sherertz, 2006, Comparative in vitro efficacies of various catheter lock solutions, Antimicrob Agents Chemother, 50, 1865, 10.1128/AAC.50.5.1865-1868.2006 · DOI
  185. Lepape, 2005, Is there any microbiologically-based specificity of the management of catheter related infections?, Ann Fr Anesth Reanim, 24, 298, 10.1016/j.annfar.2005.01.006 · DOI
  186. Capdevila, 2001, Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique, Clin Microbiol Infect, 7, 206, 10.1046/j.1469-0691.2001.00233.x · DOI
  187. Jørgensen, 2011, A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds, Int J Low Extrem Wounds, 10, 218, 10.1177/1534734611426755 · DOI
  188. Döring, 2007, A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients, Proc Natl Acad Sci USA, 104, 11020, 10.1073/pnas.0702403104 · DOI
  189. Ullmann, 2012, ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases, Clin Microbiol Infect, 18, 1, 10.1111/1469-0691.12037 · DOI
  190. Høiby, 1977, Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey, Acta Pathol Microbiol Scand, 262, 3
  191. Baltimore, 1989, Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration, Am Rev Respir Dis, 140, 1650, 10.1164/ajrccm/140.6.1650 · DOI
  192. Lefmann, 2006, Evaluation of peptide nucleic acid-fluorescence in situ hybridization for identification of clinically relevant mycobacteria in clinical specimens and tissue sections, J Clin Microbiol, 44, 3760, 10.1128/JCM.01435-06 · DOI
  193. Hall-Stoodley, 2006, Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media, JAMA, 296, 202, 10.1001/jama.296.2.202 · DOI
  194. Nistico, 2011, Adenoid reservoir for pathogenic biofilm bacteria, J Clin Microbiol, 49, 1411, 10.1128/JCM.00756-10 · DOI
  195. Homøe, 2009, Morphological evidence of biofilm formation in Greenlanders with chronic suppurative otitis media, Eur Arch Otorhinolaryngol, 266, 1533, 10.1007/s00405-009-0940-9 · DOI
  196. Marrie, 1982, A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead, Circulation, 66, 1339, 10.1161/01.CIR.66.6.1339 · DOI
  197. Waar, 2005, Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples, J Med Microbiol, 54, 937, 10.1099/jmm.0.46022-0 · DOI
  198. Costerton, 2011, New methods for the detection of orthopedic and other biofilm infections, FEMS Immunol Med Microbiol, 61, 133, 10.1111/j.1574-695X.2010.00766.x · DOI
  199. Veeh, 2003, Detection of Staphylococcus aureus biofilm on tampons and menses components, J Infect Dis, 188, 519, 10.1086/377001 · DOI
  200. Marrie, 1983, Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy, J Clin Microbiol, 18, 1388, 10.1128/JCM.18.6.1388-1398.1983 · DOI

200 of 208 shown

Cited by

Sorted by citations

Metadata

Authors
Høiby, N., Bjarnsholt, T., Moser, C., Bassi, G. L., Coenye, T., Donelli, G., Hall-Stoodley, L., Holá, V., Imbert, C., Kirketerp-Møller, K., Lebeaux, D., Oliver, A., Ullmann, A. J., & Williams, C.
Venue
Clinical Microbiology and Infection
Publisher
Elsevier BV
Published
2015-05
Volume
21
Pages
S1-S25
ISSN
1198-743X
DOI
10.1016/j.cmi.2014.10.024
Cited by
726
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review